Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging insights into new therapeutic approaches. Current efforts centers on targeting the underlying causes of MSA. One approach under investigation involves drug-based interventions to influence the dysregulation of specific